Seoul, South Korea

Hae-Kwan Eo


Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Innovations by Hae-Kwan Eo: Pioneering Pharmaceutical Compositions for Arthritic Diseases**

Introduction

Hae-Kwan Eo is a distinguished inventor based in Seoul, South Korea, recognized for his significant contributions to the field of pharmaceuticals, particularly in the treatment of arthritic diseases. With a focus on innovative herbal compositions, Eo's work addresses critical health challenges faced by many individuals suffering from inflammation and arthritis.

Latest Patents

Hae-Kwan Eo holds a notable patent titled "Crude drug compositions for treating or preventing arthritic diseases and the preparation process." This invention relates to a pharmaceutical composition that predominantly includes herbal extracts, specifically Pericarpium, which is vital for both the prevention and treatment of arthritic conditions. The composition showcases potent anti-inflammatory and anti-arthritic properties, providing a promising avenue for medical applications.

Career Highlights

Eo's career is marked by his commitment to advancing herbal medicine through scientific research. His innovative patent reflects his dedication to developing effective treatments that enhance the quality of life for arthritis patients. Eo’s work is a testament to the intersection of traditional medicine and modern pharmaceutical practices.

Collaborations

During his career, Hae-Kwan Eo has had the opportunity to collaborate with talented professionals, including Byung-Wook Cho and Mirim Jin. Together, they contribute to the mission of Pangenomics Co., Ltd., exploring new frontiers in medicine and bringing groundbreaking solutions to the healthcare industry.

Conclusion

Hae-Kwan Eo exemplifies the role of modern inventors in transforming healthcare through innovation. His patent not only highlights his ingenuity but also signifies a crucial step forward in treating arthritic diseases. With ongoing collaborations and a commitment to research, Eo continues to pave the way for future advancements in pharmaceutical compositions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…